Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer

NCT01346371 is registered in ClinicalTrials.gov with Minnesota Eye Consultants, P.A. as lead sponsor.

NCT NCT01346371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01346371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer
Lead sponsor
Minnesota Eye Consultants, P.A.
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2011
Completion date
September 30, 2012
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic conjunctivitis